Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Dundee Scientists on road to sure for "Butterfly Children" condition

13.05.2005


Scientists in Dundee have embarked on a major research programme funded by the charity DebRA which it is hoped will ultimately lead to a successful treatment for a previously incurable genetic skin condition.



DebRA has awarded a grant of £1.6 million to Professor Irwin McLean and Professor Birgitte Lane for a five-year research project into the condition, Epidermolysis Bullosa.

Epidermolysis Bullosa (EB) is a rare genetic condition in which the skin and body linings blister at the slightest knock or rub, causing painful, open wounds. At its mildest, the condition is confined to the hands and feet making holding things and walking extremely painful. In more severe forms all the body is affected and the wounds heal very slowly, giving rise to scarring, physical deformity and significant disability. People with the more severe types of EB also have an exceptionally high risk of developing skin cancers, shortening their lives by approximately 30-40 years. In its most severe form, the condition is fatal in infancy.


Both Prof McLean and Prof Lane have been involved in groundbreaking research into EB at Dundee’s Medical School and School of Life Sciences for several years, particularly into EB Simplex, the most common form of EB. This new injection of grant funding from DebRA will allow them to build on the large body of work they have already completed.

"The genes which cause EB Simplex and other forms of EB were discovered here in Dundee," said Prof McLean. "We now have data which will help us move towards a treatment for EB Simplex. A gene therapy treatment has been developed which involves the use of ’RNA interference’, a new method which can effectively switch off faulty genes. This is a very promising way of bringing about a treatment. The project will hopefully bring a treatment from the lab, through safety tests, and then to clinical trials by the time the five-year programme is drawing to a conclusion."

It is envisaged that clinical trials will be carried out at the new Clinical Research Centre at Ninewells Hospital in Dundee, the roof of which is a design inspired by butterfly wings in recognition of the work carried out by the Dundee scientists. The sufferers of EB are often known as "Butterfly Children" because their skin can be as fragile as a butterfly’s wings.

Prof McLean hailed the development of the Clinical Research Centre as a vital boon to the research programme. "There is space within the new building for us to do gene therapy trials, where we will be able to have small numbers of patients come in and get new, very specialised treatments," said Prof McLean. "To have a facility like that upon our doorstep is a huge boost for us; it formed an important part of this grant application, because we were able to show the various aspects of research and trials that we can carry forward here in Dundee. By the time the Clinical Research Centre is complete, we would hope to be moving our first patients on to clinical testing, so the timing could not be better."

Any major breakthrough on a treatment for EB Simplex could have wider implications, as there are dozens of other conditions caused by keratin genes similar to the ones responsible for EB.

DebRA’s Director for Scotland, Robin Hood, said: "Our charity funds research into an effective cure for EB and also boasts the best specialist Health Care Team in the world, providing support to 400 affected people in Scotland. Our publicity was boosted last year by the award winning Channel 4 documentary, "The Boy Whose Skin Fell Off", featuring Jonny Kennedy.

"Although we are a little-known charity, we are currently third in the league table of those seeking a cure for genetic conditions, lying behind Muscular Dystrophy and Cystic Fibrosis. Our success is due to Prof McLean and Prof Lane’s work into EB and DebRA is delighted to fund the next five-year research programme through the £1.6 million grant. With little state funding available, the majority of our funding is raised by the general public. Without continued financial support from the people of Scotland an effective treatment for this horrific condition will take so much longer to find."

Roddy Isles | alfa
Further information:
http://www.dundee.ac.uk/pressreleases/prmay05/butterfly.html

More articles from Life Sciences:

nachricht Multi-institutional collaboration uncovers how molecular machines assemble
02.12.2016 | Salk Institute

nachricht Fertilized egg cells trigger and monitor loss of sperm’s epigenetic memory
02.12.2016 | IMBA - Institut für Molekulare Biotechnologie der Österreichischen Akademie der Wissenschaften GmbH

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

Im Focus: Fraunhofer ISE Develops Highly Compact, High Frequency DC/DC Converter for Aviation

The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

UTSA study describes new minimally invasive device to treat cancer and other illnesses

02.12.2016 | Medical Engineering

Plasma-zapping process could yield trans fat-free soybean oil product

02.12.2016 | Agricultural and Forestry Science

What do Netflix, Google and planetary systems have in common?

02.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>